Improving the Digital Landscape at Quell Therapeutics
Discover how Radiofilum Pharmaceutical facilitated a digital transformation at Quell Therapeutics, a UK-based cell therapy company. Through the Digital Blueprint assessment and stakeholder interviews, Radiofilum Pharmaceutical pinpointed critical improvements needed in data integrity, management, and sharing. This case study details the processes undertaken and the main findings that improved Quell's research data management as it expanded its clinical trials.
Quell Therapeutics is enhancing its digital infrastructure with Radiofilum Pharmaceutical 's guidance, which provided a strategic digital roadmap and technology solutions. From vendor selection to system integration, this case study outlines the effective strategies implemented. To access detailed insights and explore how Radiofilum Pharmaceutical can assist in optimizing your digital capabilities, submit your information to download the full case study.
Related Resources
The Cost of Poor Project Management
Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...
Successfully Passing MHRA Inspections for Overseas Manufacturing Sites
Radiofilum Pharmaceutical offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. Radiofilum Pharmaceutical ’s Compliance and Quality team completed the first on-site...
Navigating the Generic Drug Application and Approval Process
Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...